Core Viewpoint - Ark Health (06086) has successfully completed a placement and subscription of shares, raising approximately HKD 144.3 million for the development of its AI-driven chronic disease management platform [1] Group 1: Share Placement and Subscription - The placement of a total of 45.181 million shares was completed at a price of HKD 3.32 per share, with shares allocated to no fewer than six subscribers [1] - The subscription was finalized on February 2, 2026, with the same number of shares issued at the same price, representing approximately 3.26% of the company's enlarged issued share capital [1] Group 2: Use of Proceeds - Approximately 90% of the net proceeds will be allocated to accelerate the development of the AI-driven chronic disease management platform, including model development, infrastructure expansion, talent acquisition, data collection, and the launch of AI-enhanced services [1] - The remaining 10% of the proceeds will be used for working capital and other general corporate purposes [1]
方舟健客完成先旧后新配售4518.1万股 净筹约1.443亿港元